Basic Search
|
Summaries
|
Advanced Search
Violation Tracker Current Parent Company Summary
Current Parent Company Name: Takeda Pharmaceutical
Ownership Structure: publicly traded
Headquartered in: Japan
Major Industry: pharmaceuticals
Specific Industry: pharmaceuticals
Penalty total since 2000: $3,987,516,447
Number of records: 32
| Top 5 Offense Groups (Groups Defined) | Penalty Total | Number of Records |
| safety-related offenses | $2,400,222,170 | 4 |
| government-contracting-related offenses | $1,267,699,910 | 11 |
| competition-related offenses | $235,511,367 | 10 |
| healthcare-related offenses | $56,500,000 | 2 |
| employment-related offenses | $26,750,000 | 2 |
| Top 5 Primary Offense Types | Penalty Total | Number of Records |
| drug or medical equipment safety violation | $2,400,000,000 | 1 |
| False Claims Act and related | $1,267,699,910 | 11 |
| price-fixing or anti-competitive practices | $234,113,367 | 8 |
| off-label or unapproved promotion of medical products | $56,500,000 | 2 |
| benefit plan administrator violation | $22,000,000 | 1 |
Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the
Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.
Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found
here.
Individual Penalty Records:
Click on the company or penalty amount for more information on each case.
| Company | Primary Offense Type | Year | Agency | Penalty Amount  |
| Takeda Pharmaceutical Co. Ltd. | drug or medical equipment safety violation | 2015 | private lawsuit-federal | $2,400,000,000 |
| TAP Pharmaceutical Products Inc. | False Claims Act and related | 2001 | DOJ_CIVIL | $875,000,000 |
| Shire Pharmaceuticals LLC | False Claims Act and related | 2017 | DOJ_CIVIL | $350,000,000 |
| TAP Pharmaceutical Products | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $150,000,000 |
| Shire Pharmaceuticals LLC | off-label or unapproved promotion of medical products | 2014 | FDA | $56,500,000 |
| TAP Pharmaceutical Products, Inc. | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
| Takeda Chemical | price-fixing or anti-competitive practices | 2000 | private lawsuit-federal | $22,000,000 |
| Takeda Chemical Industries Ltd. | price-fixing or anti-competitive practices | 2003 | private lawsuit-federal | $22,000,000 |
| Takeda Pharmaceuticals | benefit plan administrator violation | 2023 | private lawsuit-federal | $22,000,000 |
| Takeda Pharmaceuticals | False Claims Act and related | 2023 | TX-AG | $21,350,000 |
| Shire Pharmaceuticals LLC | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,786,034 |
| Takeda Chemical | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
| Shire US Inc. | price-fixing or anti-competitive practices | 2016 | private lawsuit-federal | $14,750,000 |
| Shire Pharmaceuticals LLC | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $6,104,000 |
| Takeda Chemical | price-fixing or anti-competitive practices | 2000 | CA-AG | $5,850,550 |
| Takeda Pharmaceuticals U.S.A. | False Claims Act and related | 2019 | IL-AG | $5,833,333 |
| TAP Pharmaceutical Products | False Claims Act and related | 2011 | PA-AG | $5,240,797 |
| Baxalta US Inc. | wage and hour violation | 2019 | private lawsuit-state | $4,750,000 |
| Shire | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
| Takeda/Tap Pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
| Takeda Pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
| Shire LLC | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
| TAP Pharmaceutical Products, Inc. | kickbacks and bribery | 2006 | WI-AG | $798,000 |
| TAP Pharmaceutical Products, Inc. | kickbacks and bribery | 2006 | KY-AG | $600,000 |
| Shire Human Genetic Therapies, Inc. | environmental violation | 2021 | MA-AG | $600,000 |
| TAP Pharmaceutical Products, Inc. | False Claims Act and related | 2001 | AR-AG | $525,780 |
| TAP Pharmaceutical Products, Inc. | consumer protection violation | 2006 | ID-AG | $198,000 |
| BAXTER HEALTHCARE CORP DBA BAXTER BIOSCIENCE | workplace safety or health violation | 2011 | OSHA | $195,000 |
| Takeda Chemical | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
| Baxalta US, Inc. | air pollution violation | 2017 | CA-SCAQMD | $35,000 |
| SHIRE PLC | workplace safety or health violation | 2016 | OSHA | $19,070 |
| SHIRE CORP | workplace safety or health violation | 2002 | OSHA | $8,100 |
